Faculty profile

Fabien Touzot

ResearcherMicrobiologie et immunologieUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Fabien Touzot

Researcher

Microbiologie et immunologie

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
20 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Autophagy Chronic Granulomatous Disease Gasdermin Mitochondria Nlrp3 Inflammasome Nox2 Reactive Oxygen Species

Latest papers

Functional stratification of MEFV variants by flow cytometric assessment of pyrin inflammasome activation.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026 · senior author
Safety of multitargeted therapy using 2 biologics or 1 biologic and 1 JAKi in refractory paediatric inflammatory disorders: a retrospective multicentric cohort.
Annals of the rheumatic diseases · 2026
NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome.
The Journal of allergy and clinical immunology · 2026 · senior author

All 27 publications

Latest funding

Regulation of the inflammatory response by NOX2-derived reactive oxygen species
CIHR · 2021 · Nominated PI
$300,000
New Modalities of Chimeric Antigen Receptor (CAR) Therapies in Pediatric Rhabdomyosarcoma
CIHR · 2021 · Co-investigator
$460,000
Alternatives to current Chimeric-Antigen Receptor (CAR)-T cell therapy in acute lymphoblastic leukemia
CIHR · 2017 · Co-investigator
$688,500

All 3 grants and awards

27 publications.

Functional stratification of MEFV variants by flow cytometric assessment of pyrin inflammasome activation.

Monjarret B, Fernandez I, Morin MP, Labrosse R, Samaan K, Barsalou J, Leveillé K, Martin C, Fabié A, Cros G, Haddad E, De Bruycker JJ, Touzot F

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2026Senior author

DOI: 10.1111/pai.70457 PMID: 42598795

Safety of multitargeted therapy using 2 biologics or 1 biologic and 1 JAKi in refractory paediatric inflammatory disorders: a retrospective multicentric cohort.

Triaille C, Jannone G, Boulanger C, De Bruycker JJ, De Somer L, Dehoorne J, Deslandres C, Dirks M, Groleau V, Grzywacz K, Haddad E, Halac U, Jantchou P, Kraus R, Labrosse R, Morin MP, Renson T, Scheers I, Touzot F, Chapuy L, Barsalou J

Annals of the rheumatic diseases2026

DOI: 10.1016/j.ard.2026.01.007 PMID: 41680028

NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome.

Monjarret B, Shour S, Stanga D, Benyoucef A, Heckel E, Marchitto L, Leiding JW, Cros G, Fernandez I, Joyal JS, Touzot F

The Journal of allergy and clinical immunology2026Senior author

DOI: 10.1016/j.jaci.2023.09.030 PMID: 37805023

Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency.

Desjardins A, Marois L, Donkó Á, Cros G, Bédard MA, Paul ML, Hsu AP, Darbinian E, Gosse G, Leto TL, Chapdelaine H, Massé C, Fernandez I, Touzot F, Sebajang H, Falcone EL

Frontiers in immunology2026

DOI: 10.3389/fimmu.2026.1723142 PMID: 41685306

A novel pathogenic variant in PSTPIP1 highlights the diversity of PSTPIP1-associated disorders.

Farajzadeh N, Triaille C, Monjarret B, Lamothe S, Touzot F, Cros G

Rheumatology (Oxford, England)2026

DOI: 10.1093/rheumatology/keaf466 PMID: 40900646

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome.

Triaille C, Beauchemin J, Campeau PM, Chapdelaine H, Dery J, Kondyli M, Mitchell G, Powell J, Turpin S, Cros G, Touzot F

British journal of haematology2026Senior author

DOI: 10.1111/bjh.70220 PMID: 41139940

Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report.

Arnold DE, Leiding JW, Logan B, Marsh RA, Griffith LM, Grunebaum E, Murguía-Favela L, Mallhi K, Chellapandian D, Deal CL, Lim SS, Prasad V, Heimall J, Chandrakasan S, Chen K, Yu LC, Seroogy CM, Gillio A, Bednarski JJ, Kapoor N, Moore TB, Cuvelier GDE, Touzot F, Rayes A, Ebens CL, Schaefer E, Bauchat A, Chopek A, Burroughs L, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson T, Malech HL, Kang EM, Parikh S

Transplantation and cellular therapy2026

DOI: 10.1016/j.jtct.2025.05.020 PMID: 41046057

Early-onset systemic lupus erythematosus-ANCA-associated vasculitis overlap syndrome caused by DNASE1L3 deficiency.

Triaille C, Makita S, Côté K, Benoit G, Campeau PM, De Bruycker JJ, Ra A, McCord JJ, Sayasith K, Sutton RB, Touzot F, Haddad E, Reizis B, Morin MP

Rheumatology (Oxford, England)2025

DOI: 10.1093/rheumatology/keaf459 PMID: 40880305

Daratumumab in Heart Transplantation: A Pilot Study in a Pediatric and Young Adult Series.

Tuta RS, Touzot F, Laroussi NA, Tremblay-Gravel M, Tremblay L, Raboisson MJ

Pediatric transplantation2025

DOI: 10.1111/petr.70166 PMID: 40960031

Autoimmune hepatitis and immune dysregulation: A case series.

Jannone G, Triaille C, Touzot F, Alvarez F

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver2025

DOI: 10.1016/j.dld.2025.07.045 PMID: 40819988

Something wrong or missing on this profile? Suggest a correction

Fabien Touzot

Research

Latest papers

Latest funding

Functional stratification of MEFV variants by flow cytometric assessment of pyrin inflammasome activation.

Safety of multitargeted therapy using 2 biologics or 1 biologic and 1 JAKi in refractory paediatric inflammatory disorders: a retrospective multicentric cohort.

NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome.

Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency.

A novel pathogenic variant in PSTPIP1 highlights the diversity of PSTPIP1-associated disorders.

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome.

Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report.

Early-onset systemic lupus erythematosus-ANCA-associated vasculitis overlap syndrome caused by DNASE1L3 deficiency.

Daratumumab in Heart Transplantation: A Pilot Study in a Pediatric and Young Adult Series.

Autoimmune hepatitis and immune dysregulation: A case series.

Regulation of the inflammatory response by NOX2-derived reactive oxygen species

New Modalities of Chimeric Antigen Receptor (CAR) Therapies in Pediatric Rhabdomyosarcoma

Alternatives to current Chimeric-Antigen Receptor (CAR)-T cell therapy in acute lymphoblastic leukemia

Frequent collaborators

Elie Haddad

Luis Murguia-Favela

Nicola Wright

Maxime Tremblay-Gravel

Laurence Chapuy

Michel Duval

Hélène Decaluwe

Prévost Jantchou

Jean-Sébastien Joyal

Christian Renaud

Hélène Decaluwe

Sonia Cellot